生物活性 | |||
---|---|---|---|
描述 | Yonkenafil (Tunodafil), a novel phosphodiesterase 5 (PDE5) inhibitor, effectively reduces cerebral infarction, neurological deficits, edema, and neuronal damage in affected areas. It may enhance cognitive function through neurogenesis modulation and potentially treats Alzheimer's disease[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.05mL 0.41mL 0.21mL |
10.25mL 2.05mL 1.03mL |
20.51mL 4.10mL 2.05mL |
参考文献 |
---|